[The French glaucoma and ocular hypertension 1-day study].

[1]  P. Kenigsberg.  Changes in Medical and Surgical Treatments of Glaucoma between 1997 and 2003 in France , 2006, European journal of ophthalmology.

[2]  Y. Leung,et al.  Genetic and environmental risk factors for primary open-angle glaucoma. , 2004, Chinese medical journal.

[3]  Philip P. Chen.  Risk and risk factors for blindness from glaucoma , 2004, Current opinion in ophthalmology.

[4]  C. Baudouin,et al.  Glaucome et hypertonie oculaire : importance de la pression intraoculaire cible dans la prise en charge thérapeutique en France. , 2003 .

[5]  F. Jónasson,et al.  Prevalence of open-angle glaucoma in Iceland: Reykjavik Eye Study , 2003, Eye.

[6]  M. Wilson,et al.  Ocular Hypertension Treatment Study (OHTS) commentary , 2003, Current opinion in ophthalmology.

[7]  A. Azuara-Blanco,et al.  The impact of new drugs on management of glaucoma in Scotland: observational study , 2001, BMJ : British Medical Journal.

[8]  M. Simon,et al.  Les ophtalmologues : densités géographiques et tendances d'évolution à l'horizon 2020 , 2000 .

[9]  H. Taylor,et al.  The prevalence of glaucoma in the Melbourne Visual Impairment Project. , 1998, Ophthalmology.

[10]  P T de Jong,et al.  The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. , 1994, Ophthalmology.

[11]  R. Klein,et al.  Prevalence of glaucoma. The Beaver Dam Eye Study. , 1992, Ophthalmology.

[12]  J. Rouland,et al.  Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France. , 2003, European journal of ophthalmology.

[13]  F. Blanchard,et al.  [Epidemiological data on primary open-angle glaucoma and treatment in the department of Marne]. , 1993, Journal francais d'ophtalmologie.